Chrysalis BioTherapeutics, Inc. is a privately held biopharmaceutical company developing regenerative drugs that mimic the body’s natural signals to activate endothelial progenitor cells and stem cells to stimulate tissue repair and restore normal tissue function. Chrysalis BioTherapeutics was incorporated in Delaware in 2012 to develop innovative peptide therapeutics to save lives and improve life’s quality.
Chrysalis’ lead drug candidate, TP508, was initially developed to accelerate healing of dermal and musculoskeletal injuries. It proved to be especially effective in promoting healing of diabetic foot ulcers in early human clinical trials and is under development as a treatment for mass casualty injuries and burns. Chrysalis has demonstrated that TP508 mitigates effects of radiation exposure. Chrysalis is therefore collaborating with US government agencies to develop TP508 as a nuclear countermeasure to combat acute and delayed radiation syndromes and to mitigate damaging effects of brain cancer radiation therapy.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 2200 Market Street,
- Phone
- +1 409-497-4083
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- chrysbio.com
- Keywords
- Show more similar pages.
- HQ
- Galveston, TX
Chrysalis Biotherapeutics, Inc. Questions
Chrysalis Biotherapeutics, Inc.'s helpline number is +1 409-497-4083
Chrysalis Biotherapeutics, Inc.'s website is chrysbio.com
Chrysalis Biotherapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/chrysalis-biotherapeutics
Chrysalis Biotherapeutics, Inc. has
6 employees.
View email and phone details for 6
employees at Chrysalis Biotherapeutics, Inc..
Chrysalis Biotherapeutics, Inc.'s industry is
Biotechnology Research
Chrysalis Biotherapeutics, Inc.'s top competitors are
Prunus Therapeutics,
Estrigenix Therapeutics, Inc.,
Hughes Biopharma Advisers Llc Clinical Operations Consulting,
Xequel Bio,
Axiom Biopharma,
Resq Pharma, Inc.,
Kinea Bio,
Perfinity Biosciences,
Citaretx,
Synovel Laboratory, Llc.
Chrysalis Biotherapeutics, Inc.'s support email address is info@chrysbio.com
Chrysalis Biotherapeutics, Inc.'s categories are Biotechnology Research
Chrysalis Biotherapeutics, Inc.'s founding year is 2009
